GlycA, an advanced inflammatory biomarker derived from NMR spectroscopy, captures chronic inflammation and is linked to various health risks, including cardiometabolic disease and long-COVID. This stable measure offers insights into systemic inflammation, making it a valuable to…
A recent review of 19 clinical trials involving over 13,000 adults highlights the varying impacts of GLP-1 medications on cardiometabolic health, emphasizing the importance of per…
GLP-1 receptor agonists are primarily known for aiding weight loss, but emerging research indicates they may also provide significant cardiovascular and renal benefits. This artic…
A recent study from the TURKAPNE registry has found that comorbid insomnia and obstructive sleep apnea (COMISA) is associated with a higher prevalence of cardiovascular disease (C…
A new clinical trial aims to investigate whether a gradual reduction in semaglutide dosage before complete cessation can lead to better weight maintenance and cardiometabolic outc…
A recent perspective paper published in Frontiers in Nutrition argues for a significant increase in protein intake, suggesting that current dietary guidelines may be outdated. Exp…
A recent study explored the interrelated pathways linking diet quality, functional ability, and cardiometabolic risk among adults with disabilities. Conducted in Palestine, the re…
The Make America Healthy Again initiative, led by US health secretary Robert F. Kennedy Jr, aims to address chronic disease and improve nutrition through new dietary guidelines. W…
A recent study from Columbia University reveals that losing about 80 minutes of sleep each night over six weeks can lead to weight gain and increased inactivity among adults. The…
A study from the University of Southern California reveals that a modified Mediterranean diet, low in protein and balanced in methionine, promotes healthier aging in mice while al…